Literature DB >> 20466687

Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.

Cheng-Jui Lin1, Chih-Jen Wu, Chi-Feng Pan, Yi-Chou Chen, Fang-Ju Sun, Han-Hsiang Chen.   

Abstract

BACKGROUND: The protein-bound uraemic toxin p-cresol is associated with immunodeficiency in haemodialysis (HD) patients. We investigated the effect of serum p-cresol, indoxyl sulphate and other variables on clinical outcomes in HD patients during a 20-month follow-up.
METHODS: We enrolled 100 stable HD patients from a single medical centre. The primary outcomes were infection-related hospitalization, cardiovascular events and all-cause mortality. Serum total and free p-cresol and indoxyl sulphate levels were measured using ultra-performance liquid chromatography. Biochemical data were collected concurrently.
RESULTS: Multivariate logistic regression analysis revealed that infection-related hospitalization correlated with free p-cresol (adjusted odds ratio: 1.70, P = 0.01) and highly sensitive C-reactive protein (hsCRP) (adjusted odds ratio: 2.07, P = 0.01); cardiovascular event was associated with free p-cresol (adjusted odds ratio: 1.78, P = 0.01) and nPCR (adjusted odds ratio: 0.01, P = 0.02); and all-cause mortality was related to albumin (adjusted odds ratio: 0.04, P = 0.01). The Kaplan-Meier method showed that free and total p-cresol were significantly associated with cardiovascular events (log-rank P < 0.01 and log-rank P < 0.01, respectively). Serum free p-cresol seemed to have a trend to correlate with infection-related hospitalization during a 20-month follow-up (log-rank P = 0.05).
CONCLUSIONS: Serum free and total p-cresol levels were significantly related to cardiovascular events. In addition, serum free p-cresol and hsCRP levels were also found to be associated with infection-related hospitalization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466687     DOI: 10.1093/ndt/gfq251

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  41 in total

1.  p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.

Authors:  Cheng-Jui Lin; Han-Hsiang Chen; Chi-Feng Pan; Chih-Kuang Chuang; Tuen-Jen Wang; Fang-Ju Sun; Chih-Jen Wu
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 2.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

3.  Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.

Authors:  Eleonora Riccio; Massimo Sabbatini; Dario Bruzzese; Lucia Grumetto; Cristina Marchetiello; Maria Amicone; Michele Andreucci; Bruna Guida; Davide Passaretti; Giacomo Russo; Antonio Pisani
Journal:  Clin Exp Nephrol       Date:  2017-11-20       Impact factor: 2.801

4.  Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.

Authors:  Vincenzo Panichi; Maria Teresa Rocchetti; Alessia Scatena; Alberto Rosati; Massimiliano Migliori; Francesco Pizzarelli; Loreto Gesualdo
Journal:  J Nephrol       Date:  2017-03-24       Impact factor: 3.902

5.  p-Cresyl sulfate promotes insulin resistance associated with CKD.

Authors:  Laetitia Koppe; Nicolas J Pillon; Roxane E Vella; Marine L Croze; Caroline C Pelletier; Stéphane Chambert; Ziad Massy; Griet Glorieux; Raymond Vanholder; Yann Dugenet; Hédi A Soula; Denis Fouque; Christophe O Soulage
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

6.  Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.

Authors:  Chao-Hung Wang; Mei-Ling Cheng; Min-Hui Liu; Ming-Shi Shiao; Kuang-Hung Hsu; Yu-Yen Huang; Cheng-Cheng Lin; Jui-Fen Lin
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

7.  Echocardiography-based pressure-volume loop assessment in the evaluation for the effects of indoxyl sulfate on cardiovascular function.

Authors:  Masaru Obokata; Koji Kurosawa; Hideki Ishida; Kyoko Ito; Tetsuya Ogawa; Yoshitaka Ando; Masahiko Kurabayashi; Kazuaki Negishi
Journal:  J Echocardiogr       Date:  2018-07-07

Review 8.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

9.  Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease.

Authors:  Shunsuke Goto; Ken Kitamura; Keiji Kono; Kentaro Nakai; Hideki Fujii; Shinichi Nishi
Journal:  Clin Exp Nephrol       Date:  2012-10-26       Impact factor: 2.801

10.  Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.

Authors:  Chih-Cheng Wu; Mu-Yang Hsieh; Szu-Chun Hung; Ko-Lin Kuo; Tung-Hu Tsai; Chao-Lun Lai; Jaw-Wen Chen; Shing-Jong Lin; Po-Hsun Huang; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.